Skip to main content
Clinical Trials/ITMCTR2000003469
ITMCTR2000003469
Not yet recruiting
Phase 4

A randomized double-blind controlled study for the clinical efficacy of the Tibetan medicine 'Fifteen Weisaierdou Pills'

Qinghai Jiumei Tibetan Medicine Pharmaceutical Co., Ltd.0 sitesTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Qinghai Jiumei Tibetan Medicine Pharmaceutical Co., Ltd.
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Qinghai Jiumei Tibetan Medicine Pharmaceutical Co., Ltd.

Eligibility Criteria

Inclusion Criteria

  • (1\) Consensus Opinions on Medical Diagnosis and Treatment of Chronic Cholecystitis and Cholecystolithiasis in China (2018\) diagnostic criteria of Chronic Cholecystitis;
  • (2\) It meets the diagnostic criteria of Tibetan medicine and is hot, with more than 5 clinical symptoms;
  • (3\) The age range is 20\-70 years old;
  • (4\) Those who voluntarily participated in the research and signed the informed consent.

Exclusion Criteria

  • (1\) Exclude patients with acute non\-calculous cholecystitis, gallbladder polyps, gallbladder cancer, gastric ulcers, gastric erosion, etc. with severe stomach disease;
  • (2\) Combined with other diseases, such as severe heart, brain, kidney, lung dysfunction and trauma;
  • (3\) Pregnant women and lactating women.
  • (4\) Have not taken other Chinese and Western medicines for treating cholecystitis within 15 days, such as Xiaoyanlidan tablets;
  • (5\) Circumstances that other researchers think are not suitable for participating in the research.

Outcomes

Primary Outcomes

Not specified

Similar Trials